Auto-Segmentation and Auto-Planning in Automated Radiotherapy for Prostate Cancer
<b>Objective:</b> The objective of this study was to develop and assess the clinical feasibility of auto-segmentation and auto-planning methodologies for automated radiotherapy in prostate cancer. <b>Methods</b>: A total of 166 patients were used to train a 3D Unet model for segmentation of the gross tumor volume (GTV), clinical tumor volume (CTV), nodal CTV (CTVnd), and organs at risk (OARs). Performance was assessed by the Dice similarity coefficient (<i>DSC</i>), the <i>Recall</i>, <i>Precision</i>, <i>Volume Ratio (VR)</i>, the 95% Hausdorff distance (<i>HD95</i>%), and the volumetric revision degree (<i>VRD</i>). An auto-planning network based on a 3D Unet was trained on 77 treatment plans derived from the 166 patients. Dosimetric differences and clinical acceptability of the auto-plans were studied. The effect of OAR editing on dosimetry was also evaluated. <b>Results</b>: On an independent set of 50 cases, the auto-segmentation process took 1 min 20 s per case. The <i>DSCs</i> for GTV, CTV, and CTVnd were 0.87, 0.88, and 0.82, respectively, with <i>VRD</i>s ranging from 0.09 to 0.14. The segmentation of OARs demonstrated high accuracy (<i>DSC</i> ≥ 0.83, <i>Recall/Precision</i> ≈ 1.0). The auto-planning process required 1-3 optimization iterations for 50%, 40%, and 10% of cases, respectively, and exhibited significant better conformity (<i>p</i> ≤ 0.01) and OAR sparing (<i>p</i> ≤ 0.03) while maintaining comparable target coverage. Only 6.7% of auto-plans were deemed unacceptable compared to 20% of manual plans, with 75% of auto-plans considered superior. Notably, the editing of OARs had no significant impact on doses. <b>Conclusions:</b> The accuracy of auto-segmentation is comparable to that of manual segmentation, and the auto-planning offers equivalent or better OAR protection, meeting the requirements of online automated radiotherapy and facilitating its clinical application.
Authors
- Lecheng Jia
- Liru He (ORCID: https://orcid.org/0000-0002-7192-0205)
- Sijuan Huang (ORCID: https://orcid.org/0000-0002-9112-5321)
- Li Chen (ORCID: https://orcid.org/0000-0002-9887-3429)
- Guangyu Wang (ORCID: https://orcid.org/0000-0003-4803-7200)
- Ting Song (ORCID: https://orcid.org/0000-0003-0768-0283)
- Ruiqi Liu (ORCID: https://orcid.org/0000-0002-2099-620X)
- Xin Yang (ORCID: https://orcid.org/0000-0002-4617-5733)
- Yang Liu (ORCID: https://orcid.org/0009-0002-3156-2236)
- Xiaoyan Huang (ORCID: https://orcid.org/0000-0002-7811-3350)
- Qian Cao (ORCID: https://orcid.org/0000-0003-3288-1714)
- Jingheng Wu (ORCID: https://orcid.org/0000-0003-0245-7525)
- Xi Lin
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Sciences (CN)
- Sun Yat-sen Memorial Hospital (CN)
- United Imaging Healthcare (China) (CN)
- Sun Yat-sen University Cancer Center (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Bioengineering
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3390/bioengineering12060620
- Citations
- 2
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 3.77
Funders
- Beijing Xisike Clinical Oncology Research Foundation